Results 31 to 40 of about 1,347 (176)

Senotherapeutics for Brain Aging Management [PDF]

open access: yesNeurology International
Brain aging is a progressive process marked by cellular dysfunction, chronic inflammation, and increased susceptibility to neurodegenerative diseases.
Timur Saliev, Prim B. Singh
doaj   +2 more sources

Lifestyle interventions to delay senescence [PDF]

open access: yesBiomedical Journal, 2023
Senescence is a condition of cell cycle arrest that increases inflammation and contributes to the development of chronic diseases in the aging human body.
Jan Martel   +2 more
doaj   +3 more sources

Molecular Regulation of SASP in Cellular Senescence: Therapeutic Implications and Translational Challenges

open access: yesCells
Cellular senescence is a complex process that significantly contributes to the pathogenesis of various diseases, including cancer and neurodegenerative disorders.
Hubert Klepacki   +3 more
doaj   +2 more sources

Reversing and modulating cellular senescence in beta cells, a new field of opportunities to treat diabetes [PDF]

open access: yesFrontiers in Endocrinology, 2023
Diabetes constitutes a world-wide pandemic that requires searching for new treatments to halt its progression. Cellular senescence of pancreatic beta cells has been described as a major contributor to development and worsening of diabetes. The concept of
Maria F. Rubin de Celis   +1 more
doaj   +2 more sources

The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases [PDF]

open access: yesBiology, 2020
Cellular senescence represents a robust tumor-protecting mechanism that halts the proliferation of stressed or premalignant cells. However, this state of stable proliferative arrest is accompanied by the Senescence-Associated Secretory Phenotype (SASP ...
Lorenzo Cuollo   +3 more
doaj   +2 more sources

Synergistic ROS Reduction Through the Co-Inhibition of BRAF and p38 MAPK Ameliorates Senescence

open access: yesAntioxidants
Reactive oxygen species (ROS)-mediated damage to macromolecules and cellular organelles is one of the major causes of senescence. Therapeutic strategies that lower ROS levels have been proposed as important treatments for senescence, but effective ...
Myeong Uk Kuk   +10 more
doaj   +2 more sources

Plant-Derived Senotherapeutics for the Prevention and Treatment of Intervertebral Disc Degeneration and Aging

open access: yesMetabolites
Chronic low back pain, a major cause of disability with a great global socioeconomic impact, has been inextricably associated with intervertebral disc degeneration.
Eleni Mavrogonatou, Dimitris Kletsas
doaj   +2 more sources

Cellular senescence in Alzheimer’s disease: from physiology to pathology

open access: yesTranslational Neurodegeneration
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders, characterized by the accumulation of Aβ and abnormal tau hyperphosphorylation. Despite substantial efforts in development of drugs targeting Aβ and tau pathologies, effective
Jing Zhu, Chongyun Wu, Luodan Yang
doaj   +2 more sources

Cellular Senescence in Skeletal Muscle Aging [PDF]

open access: yesEndocrinology and Metabolism
Cellular senescence is increasingly recognized as a pivotal mechanism driving skeletal muscle aging and the development of sarcopenia, a condition characterized by the progressive loss of muscle mass, strength, and function.
Yang Li, Huating Wang
doaj   +2 more sources

Frentizole derivatives with mTOR inhibiting and senomorphic properties [PDF]

open access: yesBiomedicine & Pharmacotherapy, 2023
Frentizole is immunosuppressive drug with low acute toxicity and lifespan-prolonging effect. Recently, frentizole´s potential to disrupt toxic amyloid β (Aβ) - Aβ-binding alcohol dehydrogenase (ABAD) interaction in mitochondria in Alzheimer´s brains has been revealed.
Zofia Chrienova   +21 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy